Drug Testing Locations - Metairie, LA

Drug Testing in Metairie, LA

Metairie, Louisiana Statistics

In 2021, Jefferson Parish, including Metairie, reported over 700 drug-related arrests.

Opioid overdoses in Metairie, LA increased by 25% from 2020 to 2021.

In Jefferson Parish, 15% of high school students reported illicit drug use.

Metairie saw a 10% increase in drug treatment admissions in 2022.

Jefferson Parish Sheriff's Office seized over $2 million in illegal drugs in 2021.

In 2021, methamphetamine was the most seized drug in Metairie, LA.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Metairie, LA & Drug Testing Policies

Employers in Metairie, LA, are increasingly implementing comprehensive drug testing policies to ensure a safe and productive work environment. These policies range from pre-employment testing to random and for-cause screening. Companies often partner with local and national testing services to ensure compliance with state regulations. For more information, visit the U.S. Department of Labor website.

Many organizations in Metairie also offer Employee Assistance Programs (EAPs) to support employees through counseling services and addiction recovery resources. This proactive approach helps reduce workplace incidents and supports employees' well-being. Local initiatives align with the Occupational Safety and Health Administration guidelines to maintain a drug-free workplace environment.

Government Efforts with Drug Problems in Metairie, LA

The government of Metairie, LA, in Jefferson Parish, is actively involved in combating drug abuse through coordinated efforts at the local and state levels. Programs like the Jefferson Parish Drug Court aim to rehabilitate offenders and provide treatment options. More on local government initiatives can be found at the Jefferson Parish Government website.

Additionally, the Louisiana Department of Health, through its Office of Behavioral Health, provides resources and support for individuals struggling with addiction. The collaborative efforts between local law enforcement and health agencies are integral to addressing the complexities of drug abuse in Metairie.

Local Drug Busts & News in Metairie, LA

In recent months, Metairie, LA, has seen increased collaboration between local law enforcement and federal agencies to combat drug-related crimes. The strategic partnership has focused on dismantling networks responsible for distributing illegal substances within the community. This initiative has led to significant arrests and the confiscation of large quantities of narcotics, illustrating the effectiveness of combined resources and intelligence.

The community of Metairie has witnessed several significant drug busts, highlighting the area's ongoing battle with narcotic distribution. Local police have successfully intercepted shipments containing various illicit drugs bound for different parts of the parish. These operations often involve extensive surveillance and the cooperation of multiple agencies, underscoring the complexity of dismantling drug trafficking organizations.

Public awareness and education have also become central to Metairie's approach to handling drug-related issues. Community events focus on educating residents about the dangers of drug abuse and the signs of trafficking within their neighborhoods. These outreach efforts encourage community involvement, fostering an environment where residents feel empowered to aid in the fight against drugs.

One of the key strategies employed by law enforcement in Metairie is the use of undercover operations that target high-traffic areas known for drug activity. Additionally, tip lines have been established, providing anonymous channels for residents to report suspicious activities. This proactive approach has resulted in the identification and arrest of several individuals linked to larger drug networks.

Beyond law enforcement actions, Metairie has seen a growing effort to offer rehabilitation and support services to those affected by drug addiction. Local organizations are working to provide resources for recovery, helping individuals break free from the cycle of substance abuse. These initiatives not only aim to address the root causes of drug problems but also to offer hope and a path forward for those impacted by narcotics.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Metairie, LA. Trusted by employers nationwide for accurate results and exceptional service.

Louisiana DOT/Non DOT Physicals

Louisiana Vision Tests

Louisiana Audiograms

Louisiana Respirator Fit Tests

Louisiana Lift Tests

Louisiana Background Checks

Clinical Testing Services

TB Testing in LA

Diabetes Testing in LA

Infectious Disease Testing in LA

Sickle Cell Anemia Testing in LA

Women/Men's Health Testing in LA

Resources & Citations

Drug Rehab Louisiana

Sober Nation Metairie

Addiction Center Metairie

Odyssey House Louisiana

Bridge House / Grace House

SAMHSA

NAMI Louisiana

Narconon New Life Retreat

The Open Door

LHC Group

Drug Testing Near Metairie, LA

Arabi, LA

Harvey, LA

Gretna, LA

Marrero, LA

Waggaman, LA

Westwego, LA

Kenner, LA

New Orleans, LA

Bridge City, LA

Harahan, LA

River Ridge, LA

Elmwood, LA

Frequently Asked Questions

Customer Reviews